Discover our Product Pipeline

Precise and reliable results for better patient care. Dermagnostix helps laboratories and clinicans stand out from the competition by innovating and redefining their portfolio.

Book a demo

Shaping the Future of Dermatological Diagnostics

Dermagnostix is the Solution for the Challenges in Dermatology

Diagnosing inflammatory skin conditions like psoriasis and eczema remains a significant challenge in dermatology. Despite advances in treatment options, patients often endure misdiagnoses and lengthy, ineffective therapies. Many laboratories still rely on subjective assessments that vary from one clinician to another, impacting diagnostic consistency. With the increasing demand for quick, accurate, and objective results – particularly for complex conditions – the need for reliable, standardized diagnostics in dermatopathology and at the point-of-care has never been greater.

Dermagnostix addresses these challenges as a visionary in molecular diagnostics in dermatology, pioneering a new era in patient care. Our innovative pipeline, featuring LymphX, PatternX and PsorX 2.0, delivers targeted, efficient diagnostic solutions tailored for labs and clinics. These products empower precise diagnosis and personalized treatment decisions by analyzing patients’ molecular profiles directly on-site. Dermagnostix’s fully automated, user-friendly solutions optimize time and resources for healthcare professionals, setting a new standard in precision dermatology for a future-focused approach to patient care.

PsorXD

Differential Diagnosis of Psoriasis and Eczema for the Point-of-Care.

PsorXD will analyze tissue samples obtained through minimal-invasive methods, such as tape strips or curettes. This will enable dermatologists to use the test directly in their office at the Point-of-Care, which will make the results available even more quickly in the highest molecular biological quality.

LymphX

Detection of Early-Stage Mycosis Fungoides versus Benign Inflammatory Skin Diseases

LymphX, a gene expression-based test, will enable the differential diagnosis of mycosis fungoides (MF), psoriasis, and eczema. Accurate and early diagnosis is needed to improve patients’ quality of life and overall life expectancy.

The most common form of cutaneous t-cell lymphoma (CTCL), mycosis fungoides (MF), is a malignant tumor of the skin that often manifests as red patches resembling benign inflammatory dermatoses. In particular in its early stages, MF mimics psoriasis or eczema, making clinical and histopathological diagnosis challenging. Latest data highlight: 35% of patients diagnosed with MF or Sézary syndrome had previously been diagnosed as AD or psoriasis.¹

¹n=4 million, Zech IM, et al. ADO-Kongress 2024, Würzburg; Abstract #eP134. 2. Howles A, et al. Br J Hosp Med (Lond) 2021;82:1–6.

More Dermagnostix Products

LabDisk-Analyzer

The LabDisk-Analyzer is a modular diagnostic system designed to process all current and future Dermagnostix LabDisks. With advanced microfluidic technology, it provides dermatopathologists and dermatologists with the scalability to efficiently conduct even rare molecular tests. This system minimizes manual errors, boosts efficiency, and accelerates the introduction of pipeline innovations, such as tests for mycosis fungoides or biomarker-based inflammation patterns.

Learn More

PsorX-LabDisk

The PsorX-LabDisk represents a breakthrough in dermatological diagnostics as the first molecular test for distinguishing psoriasis from eczema. It works seamlessly with the LabDisk-Analyzer, offering fully automated and precise gene expression analysis. As part of Dermagnostix’s innovative pipeline, the PsorX-LabDisk sets a benchmark for personalized treatment decisions, addressing unmet clinical needs in dermatopathology.  With our molecular tests, you enhance trust and confidence in clinical decisions!

Learn More

Shaping the Future of Dermatology Together!

Dermatopathology Laboratories

Discover how our user-friendly solutions can modernize your pathology lab.
Get all your questions answered and enhance diagnostic precision with our products.

Learn More

Dermatologists

Explore how our objective molecular solutions increase your diagnostic precision to make the best treatment decisions for your patients. Explore our Point-of-Care product pipeline.

More

Investors

Unlock the potential of our innovative diagnostics and see how your investment can drive advancements in medicine. Discover opportunities for growth and impact.

More

Book a meeting

Do you have questions regarding our products? Do you want to learn how to implement molecular diagnostics in your laboratory? Book a meeting now!

Book now

Do you want to learn more?

Contact our sales team! Send an email or click the button below.
info@dermagnostix.com